These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27168844)

  • 1. Efficacy and safety comparison of DL-3-n-butylphthalide and Cerebrolysin: Effects on neurological and behavioral outcomes in acute ischemic stroke.
    Xue LX; Zhang T; Zhao YW; Geng Z; Chen JJ; Chen H
    Exp Ther Med; 2016 May; 11(5):2015-2020. PubMed ID: 27168844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Efficacy of Cerebrolysin and Cerebrolysin plus Nootropics in the Treatment of Patients with Acute Ischemic Stroke in Vietnam.
    Tran L; Alvarez XA; Le HA; Nguyen DA; Le T; Nguyen N; Nguyen T; Nguyen T; Vo T; Tran T; Duong C; Nguyen H; Nguyen S; Nguyen H; Le T; Nguyen M; Nguyen T
    CNS Neurol Disord Drug Targets; 2022; 21(7):621-630. PubMed ID: 34414874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ninety-day administration of dl-3-n-butylphthalide for acute ischemic stroke: a randomized, double-blind trial.
    Cui LY; Zhu YC; Gao S; Wang JM; Peng B; Ni J; Zhou LX; He J; Ma XQ
    Chin Med J (Engl); 2013; 126(18):3405-10. PubMed ID: 24034079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Dl-3-n-Butylphthalide Combined With Human Urinary Kallidinogenase in the Treatment of Acute Ischemic Stroke.
    Zhang Y; Zhou F; Li H; Lei J; Mo Z; Li G; Wang J
    Clin Neuropharmacol; 2023 Mar-Apr 01; 46(2):60-65. PubMed ID: 36790373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobilization of Circulating Endothelial Progenitor Cells by dl-3-n-Butylphthalide in Acute Ischemic Stroke Patients.
    Zhao H; Yun W; Zhang Q; Cai X; Li X; Hui G; Zhou X; Ni J
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):752-60. PubMed ID: 26775268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
    Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
    Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Adherence to dl-3-n-Butylphthalide Treatment in Patients With Non-disabling Minor Stroke and TIA-Analysis From a Nationwide, Multicenter Registry.
    Tan Z; Zhao Y; Yang W; He S; Ding Y; Xu A
    Front Neurol; 2021; 12():720664. PubMed ID: 34630292
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of Neuroprotective Drugs in Acute Ischemic Stroke: Is It Helpful?
    Mehta A; Mahale R; Buddaraju K; Javali M; Acharya P; Srinivasa R
    J Neurosci Rural Pract; 2019 Oct; 10(4):576-581. PubMed ID: 31831974
    [No Abstract]   [Full Text] [Related]  

  • 9. A Systematic Review of Neuroprotective Efficacy and Safety of DL-3-N-Butylphthalide in Ischemic Stroke.
    Xu ZQ; Zhou Y; Shao BZ; Zhang JJ; Liu C
    Am J Chin Med; 2019; 47(3):507-525. PubMed ID: 30966774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
    Lang W; Stadler CH; Poljakovic Z; Fleet D;
    Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of Dl-3n-butylphthalide on progressive cerebral infarction: A randomized controlled STROBE study.
    Zhang C; Zhao S; Zang Y; Gu F; Mao S; Feng S; Hu L; Zhang C
    Medicine (Baltimore); 2017 Jul; 96(30):e7257. PubMed ID: 28746179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A randomized, double-blind, placebo-controlled study of Cerebrolysin safety and efficacy in the treatment of acute ischemic stroke].
    Skvortsova VI; Stakhovskaia LV; Gubskiĭ LV; Shamalov NA; Tikhonova IV; Smychkov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 11):51-5. PubMed ID: 15559222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of l-3-n-Butylphthalide within 24 h after intravenous thrombolysis for acute cerebral infarction.
    Wang M; Feng Y; Yuan Y; Gui L; Wang J; Gao P; Qin B; Sima D; Wang Q; Pan W
    Complement Ther Med; 2020 Aug; 52():102442. PubMed ID: 32951710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrolysin and early neurorehabilitation in patients with acute ischemic stroke: a prospective, randomized, placebo-controlled clinical study.
    Stan A; Birle C; Blesneag A; Iancu M
    J Med Life; 2017; 10(4):216-222. PubMed ID: 29362596
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of Cerebrolysin Treatment as an Add-On Therapy to Mechanical Thrombectomy in Patients With Acute Ischemic Stroke Due to Large Vessel Occlusion: Study Protocol for a Prospective, Open Label, Single-Center Study With 12 Months of Follow-Up.
    Staszewski J; Stȩpień A; Piusińska-Macoch R; Dȩbiec A; Gniadek-Olejniczak K; Frankowska E; Maliborski A; Chadaide Z; Balo D; Król B; Namias R; Harston G; Mróz J; Piasecki P
    Front Neurol; 2022; 13():910697. PubMed ID: 35860483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of sequential N-butylphthalide therapy on psychiatric and behavioral functions in acute ischemic stroke.
    Yang L; Li H; Wu Y; Zhang H; Du J; Chen Y
    Medicine (Baltimore); 2021 Nov; 100(46):e27860. PubMed ID: 34797324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials.
    Bornstein NM; Guekht A; Vester J; Heiss WD; Gusev E; Hömberg V; Rahlfs VW; Bajenaru O; Popescu BO; Muresanu D
    Neurol Sci; 2018 Apr; 39(4):629-640. PubMed ID: 29248999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of butylphthalide in secondary prevention of stroke: study protocol for a multicenter, real world trial based on Internet.
    Lv J; Zhao D; Zhao G; Xie Z
    BMC Neurol; 2022 Aug; 22(1):305. PubMed ID: 35986234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. dl-3-n-butylphthalide for alleviation of neurological deficit after combined extracranial-intracranial revascularization for moyamoya disease: a propensity score-matched analysis.
    Li Z; Lu J; Ma L; Wu C; Xu Z; Chen X; Ye X; Wang R; Zhao Y
    J Neurosurg; 2020 Feb; 132(2):421-433. PubMed ID: 30771781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrolysin effects on neurological outcomes and cerebral blood flow in acute ischemic stroke.
    Amiri-Nikpour MR; Nazarbaghi S; Ahmadi-Salmasi B; Mokari T; Tahamtan U; Rezaei Y
    Neuropsychiatr Dis Treat; 2014; 10():2299-306. PubMed ID: 25516711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.